Willis Towers Watson Public Limited Company (WTW) is a publicly traded company in the Financial Services — Insurance - Brokers industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Willis Towers Watson Public Limited Company (WTW) functions as a global provider of comprehensive consulting, brokerage, and solutions services. Its operations are structured across two primary divisions: Health, Wealth and Career, and Risk and Broking. Within the Health, Wealth and Career segment, WTW furnishes actuarial guidance, plan development, and administrative assistance for conventional pension and retirement savings schemes.
Is Willis Towers Watson Public Limited Company stock overvalued or undervalued in 2026?
Willis Towers Watson Public Limited Company (WTW) trades at 19.8× earnings (P/E), against a median of 13.0× across the 324 financial services companies above $2bn in Kaplio's universe. At a P/B justified by its ROE del 20,0 % (2.0×) $164 (-49 %); at its peers' median (2.8×) $231 (-28 %).
Kaplio overview: Willis Towers Watson Public Limited Company
Market cap $30B · 52 weeks $242 – $351 (8 % below the high) · P/E 19.8× · 2027 expected P/E 14.0× · Dividend 1.2 % · 9 years rising · Next earnings October 29, 2026 · expected EPS $3.59 · Closing price, Oct 28 · accounts published Jul 30.
- Valuation: P/B 3.9× (expensive).
- Business: 5-year op. margin 16.3 % (excellent).
- Balance sheet: Debt/Equity 0.92 (fragile).
- Earnings: 7 of 8 (on track).
What would it be worth at its usual multiples?
At a P/B justified by its ROE del 20,0 % (2.0×) $164 (-49 %); at its peers' median (2.8×) $231 (-28 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in insurance: 1 of 5 pass
- Book Value / Share growth −0.5 %, fails.
- Debt / Equity 0.92, fails.
- P/B (Price / Book) 3.9×, fails.
- Dividend growth streak 9 años, borderline.
- Op Margin 5y (Combined Ratio proxy) 16.3 %, passes.
Against its peers (reference peers) — Willis Towers Watson Public Limited Company: P/E 19.8×; P/B 3.9×; ROE 19.9 %; $29.9B. Brown & Brown, Inc. (P/E 19.5×; P/B 1.7×; ROE 9.7 %; $22.0B), Arthur J. Gallagher & Co. (P/E 43.1×; P/B 2.8×; ROE 6.7 %; $66.8B), Aon plc (P/E 17.3×; P/B 6.6×; ROE 40.4 %; $67.0B).
Expensive or cheap against its last ten fiscal years?
Precio / valor contable at each close: today 3.9× · median 2.6× · minimum 1.7× · maximum 4.4× · cheap below 2.3× · expensive above 3.5×. It has been cheaper than today 92% of the time over its last ten fiscal years.
Dividend
solid · Yield 1.2 % ($3.65 per ADS in 2025) · Years raising it 9 · 5-year growth +6 % a year · Free cash flow coverage payout 22 % · With $1,000 invested today you'd collect $11.80 a year ($0.98 a month).
Kaplio's reading: Willis Towers Watson Public Limited Company
Updated on October 16, 2026 · accounts published on July 30, 2026
Reading of October 15, 2026: A highly profitable business with widening margins
Willis Towers Watson Public trades at a P/E of 19.1, 34 % below its ten-year median, but at 3.6× book value against a 20 % ROE.
- Is Willis Towers Watson Public expensive or cheap? Its P/E of 19.1 is 34 % below its ten-year median of 28.8, yet 43 % above the sector median of 13.3.
- How is the business doing? Operating margin reached 23 % in fiscal 2025, far above the 13 % average of fiscal years 2014-2025.
- How strong is the balance sheet? Debt to equity is 0.92 over the last 12 months, about three times the 0.3 the insurance yardstick treats as prudent.
- What to expect from the next earnings? Analysts expect EPS of $3.59 when results come out on October 29, 2026; it beat estimates in 7 of the last 8 quarters.
- Does it underwrite with discipline and build book value? Book value per share shrank 0.5 % a year over fiscal 2020-2025, far from the 8 % annual growth the sector treats as healthy.
Is Willis Towers Watson Public expensive or cheap?
Willis Towers Watson Public trades at 3.6× book value over the last 12 months. With a 20 % ROE, the insurance yardstick justifies up to 2.0× and tolerates 2.5× at most, so the market is paying well above what profitability alone supports. The P/E is less demanding. At 19.1 over the last 12 months, it is 34 % below its ten-year median of 28.8, and the stock has traded cheaper only 7 % of the time over the decade. Against a sector median of 13.3 across 472 companies, it still carries a 43 % premium.
How is the business doing?
The business earns far more on each dollar of sales than it used to. The operating margin was 22 % over the last 12 months and 23 % in fiscal 2025, against a 13 % average across fiscal 2014-2025. Over the last 12 months the net margin was 16 % and ROE was 20 %. Growth is the weak spot: revenue fell 2.2 % year on year over the last 12 months. EPS rose 1,794 % over the same period. A jump that large points to an unusually weak comparison period and does not show the underlying trend.
How strong is the balance sheet?
Leverage is the main point against it. Debt to equity of 0.92 over the last 12 months is roughly three times the 0.3 ceiling the insurance yardstick considers prudent. That bar is strict because insurers must be able to pay claims at any moment. Shareholder returns are steadier: the dividend per share has risen for 9 consecutive fiscal years through 2025, one short of the 10 that would make it a sector aristocrat. The payout was 22 % of fiscal 2025 earnings, which leaves plenty of room, though the 1.3 % yield over the last 12 months is modest.
What to expect from the next earnings?
The next report is due on October 29, 2026, with the consensus at $3.59 of EPS for the quarter. The track record favors the company: it beat EPS estimates in 7 of the last 8 quarters. On July 30, 2026 it reported $3.35 against $3.11 expected, a 7.7 % surprise. Expectations are stable. The fiscal 2026 EPS consensus from 12 analysts barely moved over the last 30 days, from $19.83 to $19.80, and revenue estimates were also flat. Of the 29 analysts covering the stock, 17 recommend buying, 10 holding and 1 selling.
Does it underwrite with discipline and build book value?
Insurers make money in two ways: underwriting well and investing the float, which is how Buffett built Berkshire. That is why the sector tracks the operating margin over five years and the growth in book value per share, where the gains from both should pile up. Willis Towers Watson Public passes the first test with a 16 % average operating margin over fiscal 2021-2025, above the 10 % healthy mark. It fails the second: book value per share fell 0.5 % a year over fiscal 2020-2025, against an 8 % benchmark. The profits are there but have not added to book value, which helps explain the high P/B.
How this was prepared: the data comes from companies' official filings, collected by a professional provider, and from Kaplio's analysis engine (trailing-12-month ratios, 10 years of history and sector medians computed across US-listed companies). The text is written from that data alone, every figure is checked against it before publication, and it is reviewed when the company reports results. This is not investment advice.
Investor methods verdict
Would Peter Lynch approve Willis Towers Watson Public today?
The Lynch Method would wait for a better price for Willis Towers Watson Public: P/E 19.8 with 16% growth; it asks that the P/E not exceed growth. Business quality: 80 out of 100 (price not included). Lynch classifies it as a stalwart. Kaplio assessment with data from the week of 2026-10-26; not investment advice.
Profitability
| Return on Equity | 19.95% |
| Return on Invested Capital | 11.08% |
| Return on Assets | 5.12% |
| Gross Margin | 53.76% |
| Operating Margin | 22.23% |
| Net Margin | 15.49% |
Financial Health
| Debt / Equity | 0.92 |
| Current Ratio | 1.10 |
| Piotroski F-Score | 6 |
| Altman Z-Score | 1.58 |
Price Performance
| 1 month | +11.46% |
| 3 months | -4.25% |
| Year-to-date | -2.12% |
| 1 year | +1.29% |
| 3 years | +38.16% |
| 5 years | +32.75% |
| 10 years | +155.46% |
Dividend History
Paid in the last 12 months: $3.8000 per share in 4 payments.
| Date | Amount |
|---|---|
| 2026-09-30 | $0.9600 |
| 2026-06-30 | $0.9600 |
| 2026-03-31 | $0.9600 |
| 2025-12-31 | $0.9200 |
| 2025-09-30 | $0.9200 |
| 2025-06-30 | $0.9200 |
| 2025-03-31 | $0.9200 |
| 2024-12-31 | $0.8800 |
| 2024-09-30 | $0.8800 |
| 2024-06-28 | $0.8800 |
Amounts adjusted for stock splits.
Related companies: CRVL · BWIN · MRSH · AON · AJG · BRO
Explore sector: Financial Services · Insurance - Brokers
More sections of WTW: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks